hydroxyproline has been researched along with Osteoporosis, Postmenopausal in 135 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medical 'oophorectomy' by GnRH agonist or danazol is an effective treatment for endometriosis." | 9.06 | Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. ( Hirvonen, E; Nilsson, CG; Viinikka, L; Ylikorkala, O, 1990) |
| "Medical 'oophorectomy' by GnRH agonist or danazol is an effective treatment for endometriosis." | 5.06 | Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. ( Hirvonen, E; Nilsson, CG; Viinikka, L; Ylikorkala, O, 1990) |
| "Bone metabolism markers (bone alkaline phosphatase, ionized calcium, inorganic phosphorus, serum osteocalcin) and urinary excretion of hydroxyproline, Ca2+ and P after overnight fasting and of creatinine were studied in 52 female patients with endemic goiter and hypothyrosis (18 of these with decompensated hypothyrosis, 34 treated with thyroid hormones) and 48 women without thyroid diseases aged 45-60 years with menopause of no longer than 10 years (6." | 3.71 | [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology]. ( Esedova, AE; Ferzilaeva, RA; Gadzhieva, MM, 2002) |
| " Alpha, body weight, and serum albumin were all significantly lower in the osteoporotic than in the normal women, and plasma alkaline phosphatase, fasting urinary calcium, sodium, and hydroxyproline were all significantly higher in the osteoporotic than in the normal group." | 3.68 | Calcium absorption in normal and osteoporotic postmenopausal women. ( Horowitz, M; Morris, HA; Need, AG; Nordin, BE; O'Loughlin, PD, 1991) |
| "The laboratory methods for urinary bone resorption markers were enzyme immunoassays (EIA) for urinary pyridoline (PYD) and deoxypyridoline crosslinks (DPD), and for cross-linked N-telopeptides of Type I Collagen (NTx), and an HPLC assay for urinary hydroxyproline (HOP)." | 2.69 | Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis. ( Alhava, E; Arnala, I; Jääskeläinen, K; Kröger, H; Parviainen, MT, 1999) |
| "Carbocalcitonin spray administered for 12 months at a daily dosage of 80 U MRC according to five schedules has been tested on 150 normal spontaneous postmenopausal women for its influence on bone mineral density (BMD), bone metabolism and osteoarticular pain." | 2.68 | Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women. ( Abbruzzese, AD; Bottiglioni, F; Campobasso, C; De Aloysio, D; Mauloni, M; Pansini, F; Zanotti, L, 1996) |
| "Calcitriol has been widely used in the management of osteoporosis, but its efficiency is a matter of controversy." | 2.68 | Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study. ( Bayraktar, M; Gedik, O; Gürlek, A, 1997) |
| " The incidence of adverse reactions in ipriflavone-treated patients (14." | 2.68 | Efficacy of ipriflavone in established osteoporosis and long-term safety. ( Agnusdei, D; Bufalino, L, 1997) |
| " Statistical analysis examined the percent changes from baseline in bone mineral density by using an analysis of covariance with treatment as a factor and the baseline value as a covariant, by performing all-pairwise comparisons among the three estradiol groups, and by testing for a linear dose-response relationship." | 2.67 | Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. ( Field, CS; Herrmann, RR; Judd, HL; Ory, SJ; Riggs, BL; Wahner, HW, 1993) |
| "Thirty-six women with postmenopausal osteoporosis (31 of them with at least one non-traumatic vertebral compression fracture) were matched pair-wise as to age, years since menopause and body mass index and randomized to receive either cyclical estrogen-progestagen replacement treatment (group 1) or the same treatment plus nandrolone decanoate (group 2)." | 2.67 | Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis? ( Birkenhäger, JC; Birkenhäger-Frenkel, DH; Erdtsieck, RJ; Gerritsma, EJ; Kooy, PP; Luiken, GP; Mulder, P; van Kuik, C; van Veen, LC; Zeelenberg, J, 1992) |
| " We conclude that, given rectally, sCT is well absorbed and well tolerated and that it has a beneficial effect on calcium metabolism in moderately osteoporotic women." | 2.67 | Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis. ( Christiansen, C; Dirksen, KL; Hansen, MA; Overgaard, K, 1992) |
| "Biochemical parameters reflecting bone resorption [urinary calcium/creatinine (Ca/Cr) and hydroxyproline/creatinine (OH/Cr)] were related to serum estrogens [estrone (E1) and estradiol (E2)] in 262 healthy women including 158 patients receiving estrogen replacement therapy (ERT) for at least 6 months, 49 eugonadal women, and 55 untreated postmenopausal women." | 2.67 | Minimal levels of serum estradiol prevent postmenopausal bone loss. ( Albert, A; Deroisy, R; Franchimont, P; Gaspard, U; Reginster, JY; Sarlet, N, 1992) |
| "Pain was rated daily on a 10-point scale by the same observers." | 2.67 | Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. ( Karachalios, T; Lyritis, GP; Magiasis, B; Tsakalakos, N; Tsekoura, M; Yiatzides, A, 1991) |
| " The knowledge derived from this study could be adapted to the dosage schedule in long-term trials in osteoporosis." | 2.67 | Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study. ( Gärdsell, P; Johnell, O; Larsson, K; Lindh, E; Ljunghall, S; Obrant, K; Sernbo, I, 1991) |
| "Assessment of bone resorption can be achieved with measurement of urinary hydroxyproline, urinary excretion of the pyridinium crosslinks (Pyr and D-Pyr), and by measurement of plasma TRAP activity." | 2.38 | What do we know about biochemical bone markers? ( Delmas, PD, 1991) |
| "Amongst the bone resorption markers studied are: 1) Calcium/creatinine urinary quotient; 2) Tartrate resistant acid phosphatase; 3) Urinary hydroxyproline; 4) Other substance derived from collagen disruption such as hydroxylysine glycoside, piridinolinic intermolecular bridges and the enzymatic activity of proline iminopeptidase." | 2.38 | [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]. ( de la Piedra Gordo, C; Torres Jiménez, R, 1990) |
| "Twenty-eight patients with postmenopausal osteoporosis (PMO), 32 patients with postmenopausal osteopenia and 30 healthy control subjects (postmenopausal non-osteoporosis) were included in this study." | 1.39 | The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women. ( Abali, R; Celik Guzel, E; Celik, E; Guzel, S; Guzelant, AY; Kuçukyalcin, V, 2013) |
| "Osteoporosis is a common disease among patients undergoing transplantation." | 1.30 | Reduction of bone mass in women after bone marrow transplantation. ( Arranz, R; Carmona, L; Carvajal, I; Castañeda, S; Díaz, A; García-Vadillo, A, 1997) |
| "Patients with Alzheimer's disease (AD) are at increased risk for falls and hip fractures." | 1.30 | High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. ( Asoh, T; Oizumi, K; Sato, Y, 1998) |
| "The urinary excretion of bone resorption markers was tested using different assays." | 1.30 | Comparison of urinary bone resorption markers in women of 40-70 years; day-to-day and long-term variation in individual subjects. ( Gerrits, MI; Oldenhave, A; Thijssen, JH; Vecht-Hart, IM, 1998) |
| "There was a transient further rise in bone resorption for the 10 years following menopause." | 1.29 | The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90. ( Criddle, A; Devine, A; Dick, I; Garcia-Webb, P; Gutteridge, DH; Kerr, D; Price, RI; Prince, RL; St John, A, 1995) |
| "Postmenopausal osteoporosis is a major health problem." | 1.29 | Postmenopausal osteoporosis. ( Sicouri, R, 1993) |
| "We studied 21 women with postmenopausal osteoporosis, treated with salmon calcitonin nasal spray (100 IU/daily) and calcium (1 g/daily) for six months." | 1.29 | Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns. ( Montemagno, U; Riccio, S; Romano, L; Ronsini, S; Tolino, A, 1993) |
| "Alendronate 7." | 1.29 | Sustained response to intravenous alendronate in postmenopausal osteoporosis. ( Kanis, JA; Khan, S; McCloskey, EV; Vasikaran, SD, 1995) |
| "The diagnostic criterion for postmenopausal osteoporosis was a bone mineral density (BMD) (Hologic QDR-1000) in lumbar spine and/or femoral neck more than 2 SD below the mean value corresponding to an age- and sex-matched healthy control group." | 1.29 | New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis. ( de la Piedra, C; Diaz Diego, EM; Diaz Martin, MA; Disla, T; Guerrero, R; Rapado, A, 1996) |
| "The hydroxyproline data were consistent with the suggestion arising from the bone formation data that remodelling declines progressively after menopause in the controls but not in the vertebral fracture patients." | 1.28 | Bone remodelling does not decline after menopause in vertebral fracture osteoporosis. ( Bradbeer, JN; Green, JR; Hampton, L; Hesp, R; Reeve, J; Sambrook, PN; Smith, T; Wand, JS; Zanelli, JM, 1992) |
| "Calcitriol was an effective and safe treatment of postmenopausal osteoporosis." | 1.28 | Long-term treatment with calcitriol in postmenopausal osteoporosis. ( Caniggia, A; Lore, F; Martini, G; Nuti, R; Righi, G; Turchetti, V, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.22) | 18.7374 |
| 1990's | 107 (79.26) | 18.2507 |
| 2000's | 21 (15.56) | 29.6817 |
| 2010's | 4 (2.96) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, P | 1 |
| Rai, DV | 1 |
| Garg, ML | 1 |
| Celik, E | 1 |
| Guzel, S | 1 |
| Abali, R | 1 |
| Guzelant, AY | 1 |
| Celik Guzel, E | 1 |
| Kuçukyalcin, V | 1 |
| Husek, P | 1 |
| Svagera, Z | 1 |
| Vsianský, F | 1 |
| Franeková, J | 1 |
| Simek, P | 1 |
| La Vignera, S | 1 |
| Vicari, E | 1 |
| Tumino, S | 1 |
| Ciotta, L | 1 |
| Condorelli, R | 1 |
| Vicari, LO | 1 |
| Calogero, AE | 1 |
| Heaney, RP | 2 |
| Watson, P | 1 |
| Potu, BK | 1 |
| Nampurath, GK | 1 |
| Rao, MS | 1 |
| Bhat, KM | 1 |
| Chiechi, LM | 1 |
| Secreto, G | 1 |
| D'Amore, M | 1 |
| Fanelli, M | 1 |
| Venturelli, E | 1 |
| Cantatore, F | 1 |
| Valerio, T | 1 |
| Laselva, G | 1 |
| Loizzi, P | 1 |
| Ohta, H | 1 |
| Makita, K | 1 |
| Komukai, S | 1 |
| Nozawa, S | 1 |
| Blümel, JE | 1 |
| Castelo-Branco, C | 1 |
| de la Cuadra, G | 1 |
| Maciver, L | 1 |
| Moreno, M | 1 |
| Haya, J | 1 |
| Gutteridge, DH | 2 |
| Holzherr, ML | 1 |
| Retallack, RW | 1 |
| Price, RI | 2 |
| Will, RK | 1 |
| Dhaliwal, SS | 1 |
| Faulkner, DL | 1 |
| Stewart, GO | 1 |
| Stuckey, BG | 1 |
| Prince, RL | 2 |
| Criddle, RA | 1 |
| Drury, PJ | 1 |
| Tran, L | 1 |
| Bhagat, CI | 1 |
| Kent, GN | 1 |
| Jamrozik, K | 1 |
| Efstathiadou, Z | 1 |
| Koukoulis, G | 1 |
| Stakias, N | 1 |
| Challa, A | 1 |
| Tsatsoulis, A | 1 |
| Zhang, RH | 1 |
| Chen, KJ | 1 |
| Lu, DX | 1 |
| Zhu, XF | 1 |
| Ma, XC | 1 |
| Kim, MS | 1 |
| Lee, YS | 1 |
| Mukherjee, M | 1 |
| Das, AS | 1 |
| Das, D | 1 |
| Mukherjee, S | 1 |
| Mitra, S | 1 |
| Mitra, C | 1 |
| Gambacciani, M | 4 |
| Spinetti, A | 2 |
| Taponeco, F | 2 |
| Ciaponi, M | 3 |
| Cima, GP | 1 |
| Teti, GC | 1 |
| Genazzani, AR | 3 |
| Dick, I | 1 |
| Devine, A | 1 |
| Kerr, D | 1 |
| Criddle, A | 1 |
| Garcia-Webb, P | 1 |
| St John, A | 1 |
| Reeve, J | 3 |
| Pearson, J | 1 |
| Mitchell, A | 1 |
| Green, J | 1 |
| Nicholls, A | 1 |
| Justice, J | 1 |
| Hudson, E | 1 |
| Klenerman, L | 1 |
| García-Moreno, C | 1 |
| Calvo, OM | 1 |
| Herrero, S | 1 |
| Martín, E | 1 |
| Suquía, B | 1 |
| San Román, JI | 1 |
| Martín, M | 1 |
| García-Talavera, JR | 1 |
| Calvo, JJ | 1 |
| del Pino, J | 1 |
| Silsand, T | 1 |
| Reine, A | 1 |
| Dugal, S | 1 |
| Lunde, T | 1 |
| Smedsrud, B | 1 |
| Seeberg, T | 1 |
| Delmas, PD | 6 |
| Vergnaud, P | 1 |
| Arlot, ME | 1 |
| Pastoureau, P | 1 |
| Meunier, PJ | 1 |
| Nilssen, MH | 1 |
| Isaia, G | 2 |
| Mussetta, M | 1 |
| Di Stefano, M | 2 |
| Sciolla, A | 1 |
| Triolo, S | 1 |
| Molinatti, GM | 2 |
| Jensen, JE | 1 |
| Sørensen, HA | 2 |
| Kollerup, G | 2 |
| Jensen, LB | 3 |
| Sørensen, OH | 2 |
| Falch, JA | 1 |
| Reginster, JY | 3 |
| Deroisy, R | 3 |
| Lecart, MP | 1 |
| Sarlet, N | 2 |
| Zegels, B | 1 |
| Jupsin, I | 2 |
| de Longueville, M | 1 |
| Franchimont, P | 3 |
| Mück, AO | 1 |
| Lippert, TH | 1 |
| Elders, PJ | 2 |
| Lips, P | 2 |
| Netelenbos, JC | 2 |
| van Ginkel, FC | 2 |
| Khoe, E | 2 |
| van der Vijgh, WJ | 1 |
| van der Stelt, PF | 2 |
| Meurmans, L | 1 |
| Biquet, I | 1 |
| Albert, A | 2 |
| Reid, IR | 2 |
| Wattie, DJ | 1 |
| Evans, MC | 2 |
| Gamble, GD | 2 |
| Stapleton, JP | 1 |
| Cornish, J | 1 |
| Cappagli, B | 3 |
| Maffei, S | 1 |
| Manetti, P | 1 |
| Piaggesi, L | 1 |
| Fioretti, P | 1 |
| Rozenberg, S | 2 |
| Gevers, R | 1 |
| Peretz, A | 2 |
| Vandromme, J | 1 |
| Robyn, C | 1 |
| Ham, H | 2 |
| Passeri, M | 4 |
| Pedrazzoni, M | 1 |
| Pioli, G | 1 |
| Butturini, L | 1 |
| Ruys, AH | 1 |
| Cortenraad, MG | 1 |
| Gertz, BJ | 2 |
| Shao, P | 1 |
| Hanson, DA | 1 |
| Quan, H | 1 |
| Harris, ST | 1 |
| Genant, HK | 1 |
| Chesnut, CH | 1 |
| Eyre, DR | 1 |
| Mango, D | 1 |
| Ricci, S | 1 |
| Manna, P | 1 |
| Natili, G | 1 |
| Dell'Acqua, S | 1 |
| Ward, RL | 1 |
| Morgan, G | 1 |
| Dalley, D | 1 |
| Kelly, PJ | 1 |
| Stevenson, JC | 1 |
| Hillard, TC | 1 |
| Lees, B | 1 |
| Whitcroft, SI | 1 |
| Ellerington, MC | 1 |
| Whitehead, MI | 1 |
| Affinito, P | 1 |
| Di Carlo, C | 1 |
| Primizia, M | 1 |
| Petrillo, G | 1 |
| Napolitano, V | 1 |
| Tremolaterra, F | 1 |
| Nappi, C | 2 |
| Sicouri, R | 1 |
| Seibel, MJ | 1 |
| Cosman, F | 1 |
| Shen, V | 1 |
| Gordon, S | 1 |
| Dempster, DW | 1 |
| Ratcliffe, A | 1 |
| Lindsay, R | 1 |
| Nordin, BE | 8 |
| Need, AG | 7 |
| Morris, HA | 8 |
| Horowitz, M | 7 |
| Hatori, M | 1 |
| Hasegawa, A | 1 |
| Adachi, H | 1 |
| Shinozaki, A | 1 |
| Hayashi, R | 1 |
| Okano, H | 1 |
| Mizunuma, H | 1 |
| Murata, K | 1 |
| Tolino, A | 1 |
| Romano, L | 1 |
| Ronsini, S | 1 |
| Riccio, S | 1 |
| Montemagno, U | 1 |
| Eastell, R | 3 |
| Robins, SP | 2 |
| Colwell, T | 1 |
| Assiri, AM | 1 |
| Riggs, BL | 3 |
| Russell, RG | 1 |
| Field, CS | 1 |
| Ory, SJ | 1 |
| Wahner, HW | 1 |
| Herrmann, RR | 1 |
| Judd, HL | 1 |
| Ames, RW | 1 |
| Sharpe, SJ | 1 |
| Caniggia, A | 2 |
| Nuti, R | 2 |
| Loré, F | 2 |
| Martini, G | 2 |
| Frediani, B | 1 |
| Giovani, S | 1 |
| Gennari, C | 5 |
| Agnusdei, D | 5 |
| Camporeale, A | 1 |
| Herzberg, M | 2 |
| Lusky, A | 1 |
| Blonder, J | 1 |
| Frenkel, Y | 1 |
| De Aloysio, D | 1 |
| Pansini, F | 1 |
| Campobasso, C | 1 |
| Zanotti, L | 1 |
| Abbruzzese, AD | 1 |
| Mauloni, M | 1 |
| Bottiglioni, F | 1 |
| Melis, GB | 1 |
| Cagnacci, A | 1 |
| Bruni, V | 1 |
| Falsetti, L | 1 |
| Jasonni, VM | 1 |
| Polatti, F | 1 |
| Volpe, A | 1 |
| Vasikaran, SD | 1 |
| Khan, S | 1 |
| McCloskey, EV | 2 |
| Kanis, JA | 2 |
| Guerrero, R | 1 |
| Diaz Martin, MA | 1 |
| Diaz Diego, EM | 1 |
| Disla, T | 1 |
| Rapado, A | 1 |
| de la Piedra, C | 1 |
| Body, JJ | 1 |
| Dumon, JC | 1 |
| Hotimski, A | 1 |
| Praet, JP | 1 |
| Moris, M | 1 |
| Bergmann, P | 1 |
| Sims, NA | 1 |
| Moore, RJ | 1 |
| Durbridge, TC | 1 |
| Gonnelli, S | 2 |
| Cepollaro, C | 1 |
| Montomoli, M | 1 |
| Gennari, L | 1 |
| Montagnani, A | 1 |
| Palmieri, R | 1 |
| Castañeda, S | 1 |
| Carmona, L | 1 |
| Carvajal, I | 1 |
| Arranz, R | 1 |
| Díaz, A | 1 |
| García-Vadillo, A | 1 |
| Adami, S | 2 |
| Bufalino, L | 4 |
| Cervetti, R | 2 |
| Di Marco, C | 2 |
| Di Munno, O | 2 |
| Fantasia, L | 2 |
| Isaia, GC | 3 |
| Serni, U | 2 |
| Vecchiet, L | 2 |
| Gürlek, A | 1 |
| Bayraktar, M | 1 |
| Gedik, O | 1 |
| Colwell, A | 1 |
| Hampton, L | 2 |
| Langdahl, BL | 1 |
| Loft, AG | 1 |
| Møller, N | 1 |
| Weeke, J | 1 |
| Eriksen, EF | 1 |
| Mosekilde, L | 2 |
| Charles, P | 2 |
| Heikkinen, JE | 1 |
| Selander, KS | 1 |
| Laitinen, K | 1 |
| Arnala, I | 2 |
| Väänänen, HK | 1 |
| Crepaldi, G | 2 |
| Mazzuoli, GF | 1 |
| Ortolani, S | 2 |
| Zeni, S | 1 |
| Gomez-Acotto, C | 1 |
| Mautalen, C | 2 |
| Khan, SA | 1 |
| Vasikaran, S | 1 |
| Kline, WF | 1 |
| Matuszewski, BK | 1 |
| Beneton, MN | 1 |
| Sciberras, DG | 1 |
| Holland, SD | 1 |
| Orgee, J | 1 |
| Coombes, GM | 1 |
| Rogers, SR | 1 |
| Porras, AG | 1 |
| Hyldstrup, L | 1 |
| Storm, T | 1 |
| Hansen, TS | 1 |
| Abrahamsen, B | 2 |
| Henriksen, FL | 1 |
| Hermann, AP | 2 |
| Hørder, M | 1 |
| Gram, J | 2 |
| Hannon, R | 1 |
| Blumsohn, A | 1 |
| Naylor, K | 1 |
| Mazzuoli, G | 2 |
| Sato, Y | 1 |
| Asoh, T | 1 |
| Oizumi, K | 1 |
| Gerrits, MI | 1 |
| Vecht-Hart, IM | 1 |
| Oldenhave, A | 1 |
| Thijssen, JH | 1 |
| Parviainen, MT | 1 |
| Jääskeläinen, K | 1 |
| Kröger, H | 1 |
| Alhava, E | 1 |
| Uchii, M | 1 |
| Takashima, M | 1 |
| Sugiyama, T | 1 |
| Kosaka, N | 1 |
| Benussi, C | 2 |
| Shi, WB | 1 |
| Zhang, H | 1 |
| Du, N | 1 |
| Gorai, I | 1 |
| Chaki, O | 1 |
| Taguchi, Y | 1 |
| Nakayama, M | 1 |
| Osada, H | 1 |
| Suzuki, N | 1 |
| Katagiri, N | 1 |
| Misu, Y | 1 |
| Minaguchi, H | 1 |
| Aerssens, J | 1 |
| Declerck, K | 1 |
| Maeyaert, B | 1 |
| Boonen, S | 1 |
| Dequeker, J | 1 |
| Recker, RR | 1 |
| Davies, KM | 1 |
| Dowd, RM | 1 |
| Ardissone, P | 1 |
| Ferrari, D | 1 |
| Martina, V | 1 |
| Porta, M | 1 |
| Tagliabue, M | 1 |
| Marc, J | 1 |
| Prezelj, J | 1 |
| Komel, R | 1 |
| Kocijancic, A | 1 |
| Acca, M | 1 |
| Pisani, D | 1 |
| Diacinti, D | 1 |
| Scarda, A | 1 |
| Scarnecchia, L | 1 |
| Pacitti, MT | 1 |
| D'Erasmo, E | 1 |
| Minisola, S | 1 |
| Bianchi, G | 1 |
| Manfredi, G | 1 |
| Campusano, C | 1 |
| López, JM | 1 |
| Campino, C | 1 |
| Cárdenas, I | 1 |
| Rojas, A | 1 |
| Scopacasa, F | 1 |
| Wishart, JM | 2 |
| Ostrowska, Z | 2 |
| Kos-Kudla, B | 2 |
| Swietochowska, E | 1 |
| Marek, B | 2 |
| Kajdaniuk, D | 2 |
| Górski, J | 1 |
| Gnudi, S | 2 |
| Lisi, L | 1 |
| Fini, M | 1 |
| Malavolta, N | 1 |
| Schmolke, B | 1 |
| Cleghorn, DB | 2 |
| O'Loughlin, PD | 2 |
| Schroeder, BJ | 1 |
| Vestergaard, P | 1 |
| Eiken, P | 1 |
| Brot, C | 1 |
| Kolthoff, N | 1 |
| Beck Nielsen, H | 1 |
| Pors Nielsen, S | 1 |
| Thiébaud, D | 2 |
| Bigler, JM | 1 |
| Renteria, S | 1 |
| Pache, T | 1 |
| Welti, HJ | 1 |
| Landry, M | 1 |
| Burckhardt, P | 2 |
| Ciesielska-Kopacz, N | 1 |
| Esedova, AE | 1 |
| Gadzhieva, MM | 1 |
| Ferzilaeva, RA | 1 |
| Birkenhäger, JC | 1 |
| Erdtsieck, RJ | 1 |
| Zeelenberg, J | 1 |
| van Kuik, C | 1 |
| van Veen, LC | 1 |
| Birkenhäger-Frenkel, DH | 1 |
| Luiken, GP | 1 |
| Kooy, PP | 1 |
| Gerritsma, EJ | 1 |
| Mulder, P | 1 |
| Hansen, MA | 4 |
| Hassager, C | 1 |
| Jensen, SB | 1 |
| Christiansen, C | 7 |
| Overgaard, K | 3 |
| Dirksen, KL | 1 |
| Bettica, P | 1 |
| Moro, L | 1 |
| Taylor, AK | 1 |
| Talbot, J | 1 |
| Singer, FR | 1 |
| Baylink, DJ | 1 |
| Gaspard, U | 1 |
| Purdie, DW | 1 |
| Hay, AW | 1 |
| Everett, M | 1 |
| Nakamura, T | 1 |
| Nagai, Y | 1 |
| Yamato, H | 1 |
| Suzuki, K | 1 |
| Orimo, H | 1 |
| Wand, JS | 1 |
| Green, JR | 1 |
| Hesp, R | 1 |
| Bradbeer, JN | 1 |
| Sambrook, PN | 1 |
| Smith, T | 1 |
| Zanelli, JM | 1 |
| Krakauer, JC | 1 |
| Kleerekoper, M | 1 |
| Riis, BJ | 4 |
| Puche, RC | 1 |
| Rigalli, A | 1 |
| Trumper, L | 1 |
| Dip, O | 1 |
| Pereyra, JL | 1 |
| Poudes, G | 1 |
| Roberti, A | 1 |
| Bocanera, R | 1 |
| Tozzini, R | 1 |
| Pietschmann, P | 2 |
| Resch, H | 2 |
| Krexner, E | 2 |
| Woloszczuk, W | 2 |
| Willvonseder, R | 2 |
| Aloia, JF | 1 |
| Vaswani, A | 1 |
| Yeh, JK | 1 |
| McGowan, DM | 1 |
| Ross, P | 1 |
| Lyritis, GP | 1 |
| Tsakalakos, N | 1 |
| Magiasis, B | 1 |
| Karachalios, T | 1 |
| Yiatzides, A | 1 |
| Tsekoura, M | 1 |
| Leeuwenkamp, OR | 1 |
| Hackeng, WH | 1 |
| Schlemmer, A | 2 |
| Gineyts, E | 2 |
| Riis, B | 1 |
| Ljunghall, S | 1 |
| Gärdsell, P | 1 |
| Johnell, O | 1 |
| Larsson, K | 1 |
| Lindh, E | 1 |
| Obrant, K | 1 |
| Sernbo, I | 1 |
| Schoutens, A | 1 |
| Laurent, E | 1 |
| Markowicz, E | 1 |
| Lisart, J | 1 |
| De Maertelaer, V | 1 |
| Cornuz, J | 1 |
| Paccaud, F | 1 |
| Uebelhart, D | 1 |
| Johansen, JS | 1 |
| De Nichilo, D | 1 |
| Fletcher, CD | 1 |
| Farish, E | 1 |
| Leggate, J | 1 |
| Hart, DM | 1 |
| Dambacher, MA | 1 |
| Haas, HG | 1 |
| Rüegsegger, P | 1 |
| Ripamonti, C | 1 |
| Bonini, AM | 1 |
| Pratelli, L | 1 |
| Figus, E | 1 |
| de la Piedra Gordo, C | 1 |
| Torres Jiménez, R | 1 |
| Ylikorkala, O | 1 |
| Nilsson, CG | 1 |
| Hirvonen, E | 1 |
| Viinikka, L | 1 |
| Nielsen, VA | 1 |
| Hodsman, AB | 1 |
| Fraher, LJ | 1 |
| Rico, H | 1 |
| Cabranes, JA | 1 |
| Hernandez, ER | 1 |
| Pérez del Molino, J | 1 |
| Escudero, G | 1 |
| Hartwell, D | 1 |
| Turchetti, V | 1 |
| Righi, G | 1 |
| Foldes, J | 1 |
| Steinberg, R | 1 |
| Menczel, J | 1 |
| Vega, E | 1 |
| Gonzalez, D | 1 |
| Ghiringhelli, G | 1 |
| Nardi, P | 1 |
| Tsai, KS | 1 |
| Ebeling, PR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bone Sparing by Calcium Salts With and Without Extra Phosphorus[NCT00074711] | Phase 2 | 241 participants (Actual) | Interventional | 2004-08-31 | Completed | ||
| Randomized Control Trial of Bone Loading Exercises Versus Risedronate on Bone Health in Post-Menopausal Women[NCT02186600] | Phase 3 | 276 participants (Actual) | Interventional | 2015-02-01 | Completed | ||
| A Pilot Trial of 13-cis Retinoic Acid (Isotretinoin) for the Treatment of Men With Oligoasthenoteratozoospermia[NCT02061384] | Phase 2 | 20 participants (Actual) | Interventional | 2014-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00074711)
Timeframe: Measured at baseline and 12 months
| Intervention | micromol/mmol (Mean) |
|---|---|
| Calcium Phosphate Treatment Group | 5.61 |
| Calcium Carbonate Treatment Group | 6.26 |
(NCT00074711)
Timeframe: Measured at baseline and 12 months
| Intervention | nmol bce/mmol (Mean) |
|---|---|
| Calcium Phosphate Treatment Group | 16.0 |
| Calcium Carbonate Treatment Group | 17.1 |
The principle outcome measure was change in bone mineral density (BMD) under treatment with an anabolic agent (teriparatide). (NCT00074711)
Timeframe: 12 months
| Intervention | g/cm2 (Mean) | |
|---|---|---|
| Hip Bone Mineral Density | Spine Bone Mineral Density | |
| Calcium Carbonate Treatment Group | 0.01450 | 0.0607 |
| Calcium Phosphate Treatment Group | 0.01680 | 0.0609 |
(NCT00074711)
Timeframe: Measured at baseline and 12 months
| Intervention | mg/dl (Mean) | ||
|---|---|---|---|
| S Phos | S Crt | S Ca | |
| Calcium Carbonate Treatment Group | 0.245 | 0.051 | 0.001 |
| Calcium Phosphate Treatment Group | 0.139 | -0.001 | -0.048 |
(NCT00074711)
Timeframe: Measured at baseline and 12 months
| Intervention | g/g (Mean) | |
|---|---|---|
| Ca to CRT | Ph to CRT | |
| Calcium Carbonate Treatment Group | 0.011 | -0.053 |
| Calcium Phosphate Treatment Group | 0.021 | 0.073 |
Bone mineral density (BMD, measured by dual X-ray absorptiometry - DEXA) measured at several intervals during the study. BMD measured as grams per square centimeter (g/cm2). (NCT00074711)
Timeframe: Measured at Baseline
| Intervention | g/cm2 (Mean) | |
|---|---|---|
| Baseline (Hip) | Baseline (Spine) | |
| Calcium Carbonate Treatment Group | 0.78 | 0.86 |
| Calcium Phosphate Treatment Group | 0.76 | 0.88 |
Bone mineral density is the gold standard for diagnosis of low bone mass and osteoporosis and will be measured at the spine using Dual Energy X-ray Absorptiometry (DXA). (NCT02186600)
Timeframe: Baseline,6, and 12 months
| Intervention | g/cm^2 (Mean) | ||
|---|---|---|---|
| Baseline | 6 Months | 12 Months | |
| Control | 0.889 | .887 | 0.885 |
| Exercise | 0.886 | .878 | 0.885 |
| Risedronate | 0.892 | .907 | 0.911 |
"Change in Bone Strength Index (BSI) of the distal tibia based on randomization to Control, Risedronate, or Exercise group.~BSI (mg2/mm4) at the 4% tibial site will be measured using peripheral quantitative computed tomography (pQCT)." (NCT02186600)
Timeframe: Baseline, 6, and 12 months
| Intervention | mg^2/mm^4 (Mean) | ||
|---|---|---|---|
| Baseline | 6 Months | 12 Months | |
| Control | 2098.7 | 2105.89 | 2107.2 |
| Exercise | 2001 | 1987.42 | 2009.2 |
| Risedronate | 1993.3 | 1997.32 | 2014.2 |
Bone turnover is the process of removing old bone (resorption by osteoclasts) and replacing it with new bone (formation by osteoblasts). Menopause results in a brief period (~5 years) of accelerated turnover with resorption far exceeding formation. In this study, resorption will be measured by Serum NTx. (NCT02186600)
Timeframe: Baseline, 6, 12 months
| Intervention | nanoMolar Bone Collagen Equivalents/L (Mean) | ||
|---|---|---|---|
| Baseline | 6 Months | 12 Months | |
| Control | 13.99 | 12.16 | 12.36 |
| Exercise | 15.03 | 13.36 | 13.92 |
| Risedronate | 14.31 | 10.30 | 11.42 |
Millions of sperm per ejaculate in men treated with 13-cis retinoic acid (NCT02061384)
Timeframe: Up to 20-weeks
| Intervention | Millions of sperm per ejaculate (Median) |
|---|---|
| 13-cis Retinoic Acid | 2.5 |
| Calcitriol 0.25 mcg | 3.8 |
7 reviews available for hydroxyproline and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Can biochemical markers tell us anything about rate of bone loss?
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Creatinine; Female; Humans; Hydroxyproline; Osteoporosis, | 1994 |
[The value of laboratory studies for diagnosis of osteoporosis].
Topics: Aged; Calcium; Clinical Laboratory Techniques; Estradiol; Estrogen Replacement Therapy; Estrone; Fem | 1994 |
[Biological markers of bone metabolism].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Calcium; Female; Hu | 1993 |
Biochemical markers of bone turnover: methodology and clinical use in osteoporosis.
Topics: Aging; Alkaline Phosphatase; Biomarkers; Bone Resorption; Collagen; Female; Humans; Hydroxyproline; | 1991 |
Biochemical markers of bone turnover in diagnosis and assessment of therapy.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Creatinine; Female; Humans; Hydroxyproline; Menstruation; | 1991 |
What do we know about biochemical bone markers?
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone Matrix; Bone Remodeling; Bone Resorption; Female | 1991 |
[Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
Topics: Acid Phosphatase; Adult; Biomarkers; Bone Resorption; Child; Female; Follow-Up Studies; Humans; Hydr | 1990 |
59 trials available for hydroxyproline and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Variability in the measured response of bone to teriparatide.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; | 2011 |
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.
Topics: Adult; Biomarkers; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Estrogen Replacement Th | 2002 |
Alendronate daily, weekly in conventional tablets and weekly in enteric tablets: preliminary study on the effects in bone turnover markers and incidence of side effects.
Topics: Administration, Oral; Adult; Alendronate; Bone Density; Collagen Type I; Drug Administration Schedul | 2003 |
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Calcitriol; Drug Therapy, Combination; Estro | 2003 |
A clinical study of Yigu capsule in treating postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Amidohydrolases; Bone and Bones; Bone Density; Calcium; Drugs, Chinese H | 2005 |
Prospective evaluation of calcium and estrogen administration on bone mass and metabolism after ovariectomy.
Topics: Administration, Oral; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcium; Dose-Response Rel | 1995 |
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Topics: Administration, Intranasal; Alkaline Phosphatase; Animals; Bone Density; Bone Remodeling; Calcitonin | 1995 |
Long-term effect of calcium supplementation on bone loss in perimenopausal women.
Topics: Alkaline Phosphatase; Body Mass Index; Body Weight; Bone Density; Calcium; Female; Humans; Hydroxypr | 1994 |
A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Bone Density; Calcitonin; Calcium; Calcium, Dietary; C | 1994 |
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Diphosphonates; Double-Blind Method; Female; Huma | 1994 |
Effects of nandrolone decanoate on bone mass in established osteoporosis.
Topics: Alkaline Phosphatase; Anabolic Agents; Bone Density; Double-Blind Method; Female; Humans; Hydroxypro | 1993 |
Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
Topics: Alendronate; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcium; Diphosphonates; Enzyme | 1994 |
Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Intranasal; Administration, Oral; Alkaline Phosphatase; Biom | 1993 |
Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Oral; Bone Density; Breast Neoplasms; Female; Femur Neck; Hu | 1993 |
Postmenopausal bone loss: does HRT always work?
Topics: Administration, Cutaneous; Administration, Oral; Alkaline Phosphatase; Bone Density; Calcium; Creati | 1993 |
A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Female; Fluorides; Humans; Hydroxyproline; Middle Aged; | 1993 |
The effects of walking at the anaerobic threshold level on vertebral bone loss in postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Anaerobic Threshold; Bone Density; Exercise Therapy; Female; Humans; H | 1993 |
Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial.
Topics: Adult; Bone Density; Calcium; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Es | 1993 |
Effect of calcium supplementation on bone loss in postmenopausal women.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Calcium, Dietary; Female; Humans; Hydroxyproline; Middl | 1993 |
Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
Topics: Administration, Intranasal; Adult; Aerosols; Bone and Bones; Bone Density; Calcitonin; Female; Human | 1993 |
Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women.
Topics: Administration, Intranasal; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcitonin; Dose-Res | 1996 |
Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
Topics: Amino Acids; Analgesics; Bone Density; Calcitonin; Calcium; Drug Therapy, Combination; Female; Femur | 1997 |
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.
Topics: Aged; Bone and Bones; Bone Density; Female; Humans; Hydroxyproline; Isoflavones; Middle Aged; Osteop | 1997 |
The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Density; Calcitriol; Calcium; Calcium, Dietary; Cre | 1997 |
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Analysis of Variance; Biomarkers; Bone Den | 1997 |
Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.
Topics: Aged; Biomarkers; Bone Resorption; Calcium; Chromatography, High Pressure Liquid; Cross-Linking Reag | 1997 |
Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Clodronic Acid; Collagen; Collagen Type I | 1997 |
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Biomarkers; Bone Density; | 1997 |
Efficacy of ipriflavone in established osteoporosis and long-term safety.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Bone Density; Bone Remodel | 1997 |
Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Calcium; Female; Half-Life; Humans; Hydroxypr | 1997 |
Assessment of different markers of bone resorption in postmenopausal osteoporotic women treated with pamidronate.
Topics: Aged; Amino Acids; Biomarkers; Bone Resorption; Chromatography, High Pressure Liquid; Diphosphonates | 1997 |
Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Cohort Studies; Creat | 1998 |
Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.
Topics: Aged; Anabolic Agents; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Double-Blind | 1999 |
Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
Topics: Adult; Analysis of Variance; Biomarkers; Bone Density; Contraceptives, Oral, Synthetic; Desogestrel; | 1999 |
[Clinical biochemical observations on treatment for postmenopausal osteoporosis with gusong-II].
Topics: Bone Resorption; Calcium; Drugs, Chinese Herbal; Estradiol; Female; Follow-Up Studies; Humans; Hydro | 1997 |
Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Drug Therapy, Combination; Estrogens, Conjugated | 1999 |
The effect of modifying dietary calcium intake pattern on the circadian rhythm of bone resorption.
Topics: Aged; Aged, 80 and over; Amino Acids; Bone Resorption; Calcium; Calcium, Dietary; Circadian Rhythm; | 1999 |
The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.
Topics: Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Density; Calcium; Creatinine; Die | 1999 |
VDR genotype and response to etidronate therapy in late postmenopausal women.
Topics: Aged; Biomarkers; Bone Density; Calcium; Etidronic Acid; Female; Genotype; Humans; Hydroxyproline; L | 1999 |
Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study.
Topics: Absorptiometry, Photon; Aging; Alkaline Phosphatase; Biomarkers; Bone Density; Creatinine; Estrogens | 2000 |
[Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
Topics: Alkaline Phosphatase; Analysis of Variance; Bone Remodeling; Calcitonin; Creatinine; Double-Blind Me | 2000 |
Inhibition of bone resorption by divided-dose calcium supplementation in early postmenopausal women.
Topics: Amino Acids; Biomarkers; Bone Resorption; Calcium; Dietary Supplements; Drug Administration Schedule | 2000 |
An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss.
Topics: Algorithms; Amino Acids; Animals; Biomarkers; Body Weight; Bone Density; Calcium; Calcium, Dietary; | 2001 |
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Calcium; Creatinine; Estrogen R | 1998 |
Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Cholesterol; Cholesterol, HDL; Drug Therapy, Comb | 1992 |
Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
Topics: Administration, Rectal; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcitonin; Calciu | 1992 |
Minimal levels of serum estradiol prevent postmenopausal bone loss.
Topics: Analysis of Variance; Bone Resorption; Calcium; Creatinine; Estradiol; Estrogen Replacement Therapy; | 1992 |
Short term effects of SHD 386L and levonorgestrel on bone and mineral metabolism in the postmenopause: a double-blind randomised placebo-controlled trial.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Double-Blind Method; Estradiol; Female; F | 1992 |
Biochemical short-term changes produced by hormonal replacement therapy.
Topics: Bone Remodeling; Calcitonin; Calcitriol; Calcium; Calcium Carbonate; Estrogen Replacement Therapy; F | 1991 |
Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.
Topics: Aged; Analgesics; Calcitonin; Calcium; Double-Blind Method; Female; Humans; Hydroxyproline; Osteopor | 1991 |
Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatine; Dose-Response Relationship, Drug; Female; F | 1991 |
Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
Topics: Aged; Aged, 80 and over; Analgesia; Bone Density; Bone Resorption; Calcitonin; Calcium; Double-Blind | 1991 |
Effects of three different calcium preparations on urinary calcium and hydroxyproline excretion in postmenopausal osteoporotic women.
Topics: Absorption; Aged; Biological Availability; Calcium Carbonate; Circadian Rhythm; Creatinine; Fasting; | 1991 |
Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
Topics: Alkaline Phosphatase; Analysis of Variance; Bone Density; Bone Regeneration; Calcitonin; Calcium; Da | 1990 |
Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Alkaline Phosphatase; Bone and Bones; Bone | 1990 |
Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcitriol; Calcium; Calcium Radioisotopes; Cyclic AMP; Drug | 1990 |
Effect of calcium pidolate on biochemical and hormonal parameters in involutional osteoporosis.
Topics: Aged; Alkaline Phosphatase; Calcium; Creatinine; Female; Growth Hormone; Hormones; Humans; Hydroxypr | 1990 |
Acute effect of the intranasal administration of salmon calcitonin in osteoporotic women.
Topics: Administration, Intranasal; Aged; Calcitonin; Calcium; Creatinine; Female; Humans; Hydroxyproline; M | 1989 |
Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Topics: Alkaline Phosphatase; Anabolic Agents; Bone Density; Calcium; Clinical Trials as Topic; Double-Blind | 1989 |
69 other studies available for hydroxyproline and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Zinc as a nutritional approach to bone loss prevention in an ovariectomized rat model.
Topics: Animals; Catalase; Disease Models, Animal; Female; Glutathione; Humans; Hydroxyproline; Osteoporosis | 2013 |
The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcium; | 2013 |
Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone and Bones; Bone Resorption; Dipeptides | 2008 |
L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Body Mass Index; Bone Density; Data Interpretation, St | 2008 |
Effect of Cissus quadrangularis Linn on the development of osteopenia induced by ovariectomy in rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Alkanes; Animals; Biomarkers; Bone Diseases, Metabolic; Bone | 2011 |
Bone resorption versus estrogen loss following oophorectomy and menopause.
Topics: Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcium; Collagen Type I; Creatinine; Estrad | 2002 |
Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.
Topics: Adult; Aged; Alleles; Apolipoprotein E4; Apolipoproteins E; Bone Density; Bone Diseases, Metabolic; | 2004 |
Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Biomechanical Phenomena; Body Weight; Bone and Bone | 2005 |
Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17beta-estradiol.
Topics: Acid Phosphatase; Alkaline Phosphatase; Allyl Compounds; Animals; Bone Density; Calcium; Cholesterol | 2006 |
The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Bone Development; Bone Resorption; Calc | 1995 |
Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women.
Topics: Absorptiometry, Photon; Aging; Biomarkers; Bone Density; Estrogen Replacement Therapy; Female; Human | 1995 |
Heterogeneous decrease of bone mineral density in the vertebral column of ovariectomized rats.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Analysis of Variance; Animals; Body Weight; Bone Densi | 1995 |
Urinary concentration of a specific peptide of type I collagen of bone (CrossLaps): correlation to hydroxyproline.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Collagen; Female; Humans; Hydroxyproline | 1995 |
The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Topics: Alkaline Phosphatase; Amino Acids; Analysis of Variance; Animals; Biomechanical Phenomena; Bone Dens | 1995 |
Metabolic markers for the early diagnosis of postmenopausal osteoporosis.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Creatinine; Female; Humans; Hydroxyp | 1994 |
Biological variation of biochemical bone markers.
Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Calcium; Creatinine; Female; Genetic | 1994 |
Bone loss in perimenopausal women: a longitudinal study.
Topics: Adult; Bone Density; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Longit | 1994 |
Decrease of bone mineral density during estrogen substitution therapy.
Topics: Alkaline Phosphatase; Bone Density; Creatine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate | 1993 |
Postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Body Mass Index; Bone Density; Female; Fractures, Stress; Humans; Hydroxyproli | 1993 |
Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Topics: Acid Phosphatase; Adult; Aged; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Collagen; Cro | 1993 |
The nature and significance of the relationship between urinary sodium and urinary calcium in women.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Bone Resorption; Calcium; Calcium, Dietary; Creatini | 1993 |
Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Topics: Absorptiometry, Photon; Administration, Inhalation; Aerosols; Bone and Bones; Calcitonin; Calcium; F | 1993 |
Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.
Topics: Aged; Amino Acids; Biomarkers; Bone Development; Bone Resorption; Female; Humans; Hydroxyproline; Mi | 1993 |
Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites.
Topics: Absorptiometry, Photon; Absorption; Adult; Bone Density; Calcitriol; Calcium; Female; Humans; Hydrox | 1993 |
The effect of estrogen replacement therapy on zinc in serum and urine.
Topics: Bone Density; Creatinine; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Magnesium; M | 1996 |
Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
Topics: Absorptiometry, Photon; Administration, Intranasal; Administration, Intravaginal; Alkaline Phosphata | 1996 |
Sustained response to intravenous alendronate in postmenopausal osteoporosis.
Topics: Absorptiometry, Photon; Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Calcium; Female; Humans | 1995 |
New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
Topics: Adult; Aged; Amino Acids; Biomarkers; Bone Diseases, Metabolic; Bone Resorption; Calcium; Collagen; | 1996 |
Cyclical pamidronate infusions in postmenopausal osteoporosis.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Density; Bone Remodeling; Calcium; Diphosphonates; Drug Admi | 1996 |
Estradiol treatment transiently increases trabecular bone volume in ovariectomized rats.
Topics: Alkaline Phosphatase; Analysis of Variance; Animals; Bone Density; Bone Resorption; Cell Division; D | 1996 |
Reduction of bone mass in women after bone marrow transplantation.
Topics: Adolescent; Adult; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Marrow Transplantation; | 1997 |
Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Alkaline Phosphatase; Amino Acids; Bone Density; | 1997 |
The effect of olpadronate in ovariectomized thyroxine-treated rats.
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Creatinin | 1997 |
Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Alleles; Bone Density; Bone Development; Calcitriol; C | 1998 |
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
Topics: Absorptiometry, Photon; Acid Phosphatase; Age Factors; Alkaline Phosphatase; Amino Acids; Biomarkers | 1998 |
High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bone Density; Calcium; Calcium-Binding Proteins; Extrace | 1998 |
Comparison of urinary bone resorption markers in women of 40-70 years; day-to-day and long-term variation in individual subjects.
Topics: Adult; Age Factors; Aged; Amino Acids; Biomarkers; Bone Resorption; Collagen; Collagen Type I; Enzym | 1998 |
[Effect of KW-8232 on bone turnover in ovariectomized rats].
Topics: Alkaline Phosphatase; Amino Acids; Animals; Bone Density; Bone Resorption; Calcium; Disease Models, | 1998 |
Bone metabolism in type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Biomarkers; Bone Density; Bone Resorption; Calcium; | 1999 |
Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
Topics: Absorptiometry, Photon; Adult; Analysis of Variance; Biomarkers; Bone Density; Contraceptives, Oral; | 2000 |
Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Calcium; Circadian Rhythm; Collagen; Coll | 2001 |
Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
Topics: Aged; Analgesics, Non-Narcotic; Bone Density; Calcium; Clodronic Acid; Female; Femur Neck; Follow-Up | 2001 |
[Laboratory diagnosis of osteoporosis].
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Child; | 2001 |
Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Climacteric; Creatinine; Cross-Sectional Studies; Fe | 2001 |
Dynamic pattern of IGF-I and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Calcium; Collagen Type I; Disease Models, | 2002 |
[Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Female; Goiter, Endemic; Humans; Hydroxyp | 2002 |
Is heritability a risk factor for postmenopausal osteoporosis?
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Analysis of Variance; Bone Density; Calcium; Cre | 1992 |
Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
Topics: Adult; Aged; Amino Acids; Biomarkers; Bone Resorption; Child; Chromatography, High Pressure Liquid; | 1992 |
Regulation of bone turnover and prevention of bone atrophy in ovariectomized beagle dogs by the administration of 24R,25(OH)2D3.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone and Bones; Bone Resorption; Disease Models, Animal; Dogs; | 1992 |
Bone remodelling does not decline after menopause in vertebral fracture osteoporosis.
Topics: Age Factors; Aged; Alkaline Phosphatase; Bone Remodeling; Bone Resorption; Creatinine; Female; Fract | 1992 |
Borderline-low serum thyrotropin level is correlated with increased fasting urinary hydroxyproline excretion.
Topics: Aged; Bone Diseases, Metabolic; Calcium; Creatinine; Fasting; Female; Humans; Hydroxyproline; Hyperp | 1992 |
Calcium absorption in normal and osteoporotic postmenopausal women.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Body Weight; Bone Resorptio | 1991 |
Estimation of bone turnover in climacteric women by the whole body retention of fluoride.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Climacteric; Female; Fluorides; Humans; Hydroxyprolin | 1991 |
Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Regeneration; Calcitonin; Calcium; Female; Fractures, | 1991 |
Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
Topics: Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Regeneration; Bone Resorption; Female; Humans; H | 1991 |
Serum triiodothyronine, bone turnover, and bone mass changes in euthyroid pre- and postmenopausal women.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Estradiol; Estrogens; Female; Humans; Hyd | 1991 |
[Prevalence of risk factors for osteoporosis and distribution of calciuria and hydroxyprolinuria in an elderly population of a general practice. Results of a survey among 32 practitioners of the Vaud and Fribourg districts].
Topics: Aged; Calcium; Calcium, Dietary; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteoporosis; Os | 1991 |
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
Topics: Age Factors; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcium; Creatinine; Female; Fractu | 1991 |
Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
Topics: Amino Acids; Chromatography, High Pressure Liquid; Collagen; Female; Humans; Hydroxyproline; Middle | 1991 |
Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women.
Topics: Aged; Bone Resorption; Calcium; Diet, Sodium-Restricted; Female; Humans; Hydroxyproline; Menopause; | 1991 |
Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Creatinine; Estrogen Replacement Therapy; | 1991 |
[Pathophysiology of osteoporosis and bone density determination].
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Calcium; Estrogens; Female; Humans; Hydr | 1991 |
The reproducibility of bone-related biochemical variables in post-menopausal women.
Topics: Aged; Biomarkers; Calcium; Creatine; Female; Humans; Hydroxyproline; Middle Aged; Osteoporosis, Post | 1990 |
The importance of urinary hydroxyproline and serumal osteocalcin in the evaluation of post-menopausal osteoporosis.
Topics: Adult; Aged; Bone Density; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, P | 1990 |
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
Topics: 24,25-Dihydroxyvitamin D 3; Absorptiometry, Photon; Adult; Aging; Alkaline Phosphatase; Bone and Bon | 1990 |
Long-term treatment with calcitriol in postmenopausal osteoporosis.
Topics: Aged; Bone Density; Calcitriol; Calcium; Female; Humans; Hydroxyproline; Kidney; Middle Aged; Osteoc | 1990 |
Zinc excretion in osteoporotic women.
Topics: Adult; Aged; Aged, 80 and over; Aging; Bone Density; Female; Humans; Hydroxycholecalciferols; Hydrox | 1990 |
Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
Topics: Alkaline Phosphatase; Bone and Bones; Double-Blind Method; Drug Therapy, Combination; Estradiol; Est | 1990 |
Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
Topics: Age Factors; Aged; Bone and Bones; Bone Density; Calcium; Female; Humans; Hydroxyproline; Infusions, | 1989 |